Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic

Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, Apostolis Papaefthymiou, Eleftheria Economidou, Elpidoforos S. Soteriades, Elisabeth Vardaka, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Dimitrios David Papazoglou, Michael Doulberis

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)

Abstract

The persistence of the coronavirus disease 2019 (COVID-19) pandemic has triggered research into limiting transmission, morbidity and mortality, thus warranting a comprehensive approach to guide balanced healthcare policies with respect to people’s physical and mental health. The mainstay priority during COVID-19 is to achieve widespread immunity, which could be established through natural contact or vaccination. Deep knowledge of the immune response combined with recent specific data indicates the potential inferiority of induced immunity against infection. Moreover, the prevention of transmission has been founded on general non-pharmacological measures of protection, albeit debate exists considering their efficacy and, among other issues, their socio-psychological burden. The second line of defense is engaged after infection and is supported by a plethora of studied agents, such as antibiotics, steroids and non-steroid anti-inflammatory drugs, antiviral medications and other biological agents that have been proposed, though variability in terms of benefits and adverse events has not allowed distinct solutions, albeit certain treatments might have a role in prevention and/or treatment of the disease. This narrative review summarizes the existing literature on the advantages and weaknesses of current COVID-19 management measures, thus underlining the necessity of acting based on the classical principle of “ofeleein i mi vlaptin”, that is, to help or not to harm.

Original languageEnglish
Article number309
JournalMedicina (Lithuania)
Volume58
Issue number2
DOIs
Publication statusPublished - Feb 2022
Externally publishedYes

Keywords

  • COVID-19
  • Drug therapy
  • Hippocrates
  • MRNA
  • Ofelein i mi vlaptin
  • Primum non nocere
  • SARS
  • Vaccination

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic'. Together they form a unique fingerprint.

Cite this